The most commonly reported adverse events with the AZD1222 COVID-19 vaccine are headache and fatigue, a large-scale active ...

A genome-wide association study in Sweden identified rare genetic variants near the SCAF11 and LRRC4C genes that may be ...

A half-decade since the pandemic, countless individuals and families have been left wondering: what is the long-term safety ...

To tell the story you want with statistics, you don’t have to lie or fabricate data — though that happens, too. More often, ...

Placebo testing has been part of the process since the 1940s. It’s unclear what additional measures would achieve — but it may slow development.

COVID, sparking debate about 'immunity debt.' Experts suggest that COVID-19 safety measures, while effective against the ...

As for safety, experts interviewed for this story said they are extremely confident in the systems set up to monitor vaccine ...

New genetic clues reveal why some people may be predisposed to myocarditis or pericarditis after COVID-19 vaccination, offering fresh insight into immune responses and vaccine safety. Study ...

A combination shot for flu and COVID-19 using messenger RNA generated antibodies in a study, but U.S. government regulators ...

Early COVID suppression could have prevented 180,000 UK deaths, study reveals … FDA, CDC pause chikungunya vaccine for adults ...

SOUTH SAN FRANCISCO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the "Company" or "Vaxart") today announced its business update and financial results for the first quarter of ...